Literature DB >> 23891765

Distinguishing language and race disparities in epilepsy surgery.

John P Betjemann1, Atalie C Thompson, Carlos Santos-Sánchez, Paul A Garcia, Susan L Ivey.   

Abstract

This study aimed to identify whether race/ethnicity and limited English proficiency impact the likelihood of pursuing surgical treatment for medically refractory epilepsy. We conducted a retrospective cohort study of 213 patients with medically refractory epilepsy and mesial temporal sclerosis who were being considered for temporal lobectomy between January 1, 1993 and December 31, 2010 with follow-up through December 31, 2012. Demographic and clinical factors potentially associated with surgical utilization, including self-reported race/ethnicity and preferred language, were gathered from the medical record. Patients of Asian/Pacific Islander or African American race were significantly less likely to pursue surgical treatment of epilepsy compared with non-Hispanic whites in a multivariate logistic regression model (adjusted for nonconcordant ictal EEG, age, and limited English proficiency) (OR 0.20, p=0.003; OR 0.15, p=0.001, respectively). Limited English proficiency was also significantly associated with lower odds of surgery (OR 0.38, p=0.034). Both race and limited English proficiency contribute to disparities in the surgical management of medically refractory epilepsy, especially among Asian/Pacific Islanders and African Americans. Culturally sensitive patient-physician communication and patient education materials might aid in surgical decision-making among minority groups.
© 2013.

Entities:  

Keywords:  ATL; EEG; EMU; Health disparities; Language proficiency; MTS; Mesial temporal sclerosis; NIS; Nationwide Inpatient Sample; Surgical utilization; TLE; Temporal lobectomy; UCSF; University of California, San Francisco; anterior temporal lobectomy; electroencephalogram; epilepsy monitoring unit; mesial temporal sclerosis; temporal lobe epilepsy

Mesh:

Year:  2013        PMID: 23891765     DOI: 10.1016/j.yebeh.2013.06.020

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  5 in total

1.  Investigation of bias in an epilepsy machine learning algorithm trained on physician notes.

Authors:  Benjamin D Wissel; Hansel M Greiner; Tracy A Glauser; Francesco T Mangano; Daniel Santel; John P Pestian; Rhonda D Szczesniak; Judith W Dexheimer
Journal:  Epilepsia       Date:  2019-08-23       Impact factor: 5.864

2.  Inequities in Therapy for Infantile Spasms: A Call to Action.

Authors:  Fiona M Baumer; John R Mytinger; Kerri Neville; Christina Briscoe Abath; Camilo A Gutierrez; Adam L Numis; Chellamani Harini; Zihuai He; Shaun A Hussain; Anne T Berg; Catherine J Chu; William D Gaillard; Tobias Loddenkemper; Archana Pasupuleti; Debopam Samanta; Rani K Singh; Nilika S Singhal; Courtney J Wusthoff; Elaine C Wirrell; Elissa Yozawitz; Kelly G Knupp; Renée A Shellhaas; Zachary M Grinspan
Journal:  Ann Neurol       Date:  2022-04-28       Impact factor: 11.274

3.  Quality of Antiepileptic Treatment Among Older Medicare Beneficiaries With Epilepsy: A Retrospective Claims Data Analysis.

Authors:  Maria Pisu; Joshua Richman; Kendra Piper; Roy Martin; Ellen Funkhouser; Chen Dai; Lucia Juarez; Jerzy P Szaflarski; Edward Faught
Journal:  Med Care       Date:  2017-07       Impact factor: 2.983

4.  The evolution of epilepsy surgery between 1991 and 2011 in nine major epilepsy centers across the United States, Germany, and Australia.

Authors:  Lara Jehi; Daniel Friedman; Chad Carlson; Gregory Cascino; Sandra Dewar; Christian Elger; Jerome Engel; Robert Knowlton; Ruben Kuzniecky; Anne McIntosh; Terence J O'Brien; Dennis Spencer; Michael R Sperling; Gregory Worrell; Bill Bingaman; Jorge Gonzalez-Martinez; Werner Doyle; Jacqueline French
Journal:  Epilepsia       Date:  2015-08-07       Impact factor: 5.864

Review 5.  FACETS of health disparities in epilepsy surgery and gaps that need to be addressed.

Authors:  Cody L Nathan; Camilo Gutierrez
Journal:  Neurol Clin Pract       Date:  2018-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.